🟢 Nuvation Bio is trading 5.5% up in pre-market with no clear new catalyst identified

Nuvation Bio is trading 5.54% higher in pre-market at $5.93, versus the September 29 close of $5.62; no clear new catalyst dated September 30 was identified.

• The FDA’s updated IBTROZI label approval was announced September 17, making it earlier context rather than a confirmed trigger.
• Broad index moves are modest and mixed, offering no clear market-wide explanation.